Purchase Order 36C24826P0651
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 8, awarded a $4.04 million firm fixed-price purchase order to Roche Diagnostics Corporation for histology services, with an ultimate completion date of September 30, 2028. The contract was awarded on October 1, 2023, without set-aside designation, and will be performed at the company's facility in Castleton, Indiana. This award represents a child contract under a larger indefinite delivery vehicle and responds to VISN...
- Roche Diagnostics Corporation was awarded a $352,263.44 delivery order for histology staining services on October 1, 2024, under a Firm Fixed Price contract with Veterans Integrated Service Network 8 (VISN 8), a civilian component of the Department of Veterans Affairs. The work will be performed in Castleton, Indiana, with an ultimate completion date of September 30, 2025. This award was not made under any set-aside designation and represents a child contract under a larger vehicle, leveraging...
- Roche Diagnostics Corporation was awarded a $331,157.60 firm fixed price purchase order by Veterans Integrated Service Network 21 (VISN 21), a civilian component of the Department of Veterans Affairs, on October 1, 2024. The contract, which extends through September 30, 2025, provides continued rental and support services for immunohistochemistry (IHC), in-situ hybridization (ISH), and special staining systems at the VA Palo Alto Healthcare System in Castleton, Indiana. This award was issued...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 2, awarded a delivery order valued at $181,539.67 to Roche Diagnostics Corporation for a clinical laboratory immunohistochemistry staining system. The contract employs firm fixed-price pricing and is scheduled for completion by August 31, 2027, with performance occurring in Castleton, Indiana. This delivery order represents a child contract under an existing indefinite delivery vehicle with VISN 2 for special...
- Roche Diagnostics Corporation received a $105,144.52 firm fixed-price purchase order from Veterans Integrated Service Network 8 (VISN 8), a civilian agency within the Department of Veterans Affairs. This order, awarded on January 1, 2021, represents a decrease in unused FY25 funds for special stainer capabilities and is designated as a child contract under a larger indefinite delivery vehicle. The work will be performed in Castleton, Indiana. No set-aside designation was applied to this award,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a firm fixed-price purchase order to Roche Diagnostics Corporation for IHC Reagents with a ceiling value of $689,183.79. The contract, awarded on June 12, 2025, will be performed at Roche's facility in Castleton, Indiana, with an ultimate completion date of June 11, 2026. This award carries no set-aside designation, indicating open competition. The contract represents a delivery order against Roche's...
- The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a delivery order to Roche Diagnostics Corporation on October 1, 2024, for the procurement of histology reagents. This firm fixed-price contract carries a ceiling value of $215,810.27 and is scheduled for completion by September 30, 2025. The award represents a child order under a larger indefinite delivery vehicle, consistent with Roche Diagnostics' established $5.17 million histology consumables contract with...
- Roche Diagnostics Corporation received a delivery order contract worth $735,352.07 for histology staining services under a bridge contract arrangement with Veterans Integrated Service Network 8, a civilian healthcare component of the Department of Veterans Affairs. The contract, awarded on April 1, 2025, establishes firm fixed-price terms for a dual structure encompassing both six-month and one-year bridge periods, with final completion scheduled for March 31, 2027. Performance will be delivered...
- Roche Diagnostics Corporation was awarded a delivery order valued at $186,088.66 by Veterans Integrated Service Network 6 (VISN 6) on October 1, 2023, for roche reagents and supplies. This firm fixed-price contract, which was not issued under a set-aside designation, has an ultimate completion date of September 30, 2024, and will be performed in Castleton, Indiana. The award represents a child order under VISN 6's larger indefinite delivery contract with Roche Diagnostics, which carries a...
- Roche Diagnostics Corporation was awarded a $33,040.50 firm fixed-price delivery order by Veterans Integrated Service Network 6 (VISN 6) for histology reagents, with performance at the company's Castleton, Indiana facility. The contract was awarded on October 1, 2024, with an ultimate completion date of September 30, 2025. This delivery order was issued without a set-aside designation, reflecting open competition in the federal marketplace. The award supports the Veterans Health Administration's...
The Veterans Integrated Service Network 8 (VISN 8) awarded a $239,857.65 firm fixed-price purchase order to Roche Diagnostics Corporation for emergency histology services under a one-year bridge contract. The award, issued on April 2, 2026, with a completion date of April 1, 2027, will be performed at Roche's facility in Castleton, Indiana. This contract represents a child award under a larger indefinite delivery vehicle and was awarded without set-aside designation, reflecting open competition. The procurement addresses critical diagnostic needs within the VA healthcare system, specifically for histology staining and related services that support pathology and tissue analysis operations across VISN 8's healthcare network. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, is a primary supplier of advanced diagnostic capabilities to federal healthcare agencies including the Department of Veterans Affairs, Defense Health Agency, and other civilian medical centers. The company specializes in in vitro diagnostics, laboratory instruments, and reagents, with an extensive portfolio spanning molecular diagnostics, clinical chemistry analysis, immunochemistry testing, and histology services. This emergency bridge contract reflects sustained demand for Roche's diagnostic capabilities across the VA system, where the company maintains multiple active indefinite delivery contracts and blanket purchase agreements valued at millions of dollars through 2026-2030, ensuring continuity of critical laboratory services for veteran patient care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $239.9k | 3/31/26 |